Gilead Sciences Stock Earnings Per Share

GILD Stock  USD 73.25  0.24  0.33%   
Gilead Sciences fundamentals help investors to digest information that contributes to Gilead Sciences' financial success or failures. It also enables traders to predict the movement of Gilead Stock. The fundamental analysis module provides a way to measure Gilead Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gilead Sciences stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Gilead Earnings Per Share Analysis

Gilead Sciences' Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
 2021 2022 2023 2024 (projected)
Total Revenue27.3B27.3B27.1B28.5B
Interest Expense1.0B935M944M534.5M

Earnings per Share

 = 

Earnings

Average Shares

More About Earnings Per Share | All Equity Analysis

Current Gilead Sciences Earnings Per Share

    
  4.50 X  
Most of Gilead Sciences' fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gilead Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Gilead Earnings Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for Gilead Sciences is extremely important. It helps to project a fair market value of Gilead Stock properly, considering its historical fundamentals such as Earnings Per Share. Since Gilead Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Gilead Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Gilead Sciences' interrelated accounts and indicators.
0.90.950.70.93-0.05-0.12-0.270.990.610.620.730.470.560.530.910.240.87-0.77-0.510.820.690.96-0.250.690.210.730.24-0.58-0.48-0.26
0.90.90.640.87-0.1-0.2-0.530.880.530.420.650.360.470.320.760.270.82-0.64-0.440.750.670.89-0.370.460.340.610.29-0.55-0.48-0.48
0.950.90.540.950.03-0.18-0.360.90.590.520.740.410.460.370.790.410.86-0.65-0.40.720.630.88-0.30.640.180.630.22-0.62-0.39-0.36
0.70.640.540.48-0.27-0.01-0.240.750.190.620.210.350.540.410.64-0.180.74-0.81-0.670.890.740.70.180.580.060.690.3-0.54-0.6-0.28
0.930.870.950.48-0.03-0.27-0.280.90.760.440.770.540.40.470.860.340.74-0.61-0.220.70.480.9-0.490.560.370.520.32-0.46-0.23-0.21
-0.05-0.10.03-0.27-0.030.210.47-0.090.23-0.310.27-0.11-0.260.060.040.44-0.30.40.27-0.46-0.450.02-0.21-0.360.28-0.130.210.430.270.36
-0.12-0.2-0.18-0.01-0.270.210.08-0.09-0.05-0.03-0.12-0.080.02-0.05-0.04-0.17-0.070.0-0.02-0.090.0-0.110.34-0.02-0.22-0.12-0.10.03-0.050.02
-0.27-0.53-0.36-0.24-0.280.470.08-0.230.05-0.11-0.040.08-0.030.35-0.050.04-0.530.20.24-0.44-0.53-0.210.05-0.20.0-0.1-0.070.550.320.9
0.990.880.90.750.9-0.09-0.09-0.230.60.640.710.490.580.580.930.160.85-0.8-0.540.830.70.96-0.230.690.220.750.24-0.55-0.49-0.21
0.610.530.590.190.760.23-0.050.050.60.150.580.750.020.440.750.190.21-0.310.320.34-0.10.69-0.710.110.680.020.460.10.320.21
0.620.420.520.620.44-0.31-0.03-0.110.640.150.170.520.40.210.5-0.050.66-0.9-0.60.630.670.520.270.7-0.450.64-0.42-0.58-0.38-0.19
0.730.650.740.210.770.27-0.12-0.040.710.580.170.120.330.470.790.520.52-0.28-0.280.320.320.76-0.330.330.350.580.22-0.11-0.380.09
0.470.360.410.350.54-0.11-0.080.080.490.750.520.120.060.320.55-0.020.18-0.610.230.440.00.51-0.420.210.280.010.09-0.030.370.17
0.560.470.460.540.4-0.260.02-0.030.580.020.40.330.060.650.470.010.58-0.57-0.670.540.640.490.220.64-0.170.73-0.08-0.46-0.63-0.1
0.530.320.370.410.470.06-0.050.350.580.440.210.470.320.650.650.110.25-0.36-0.250.370.160.58-0.250.460.250.470.290.0-0.180.36
0.910.760.790.640.860.04-0.04-0.050.930.750.50.790.550.470.650.170.65-0.68-0.350.70.470.96-0.290.530.390.640.35-0.24-0.340.08
0.240.270.41-0.180.340.44-0.170.040.160.19-0.050.52-0.020.010.110.170.120.030.0-0.13-0.020.24-0.31-0.02-0.010.21-0.020.05-0.010.03
0.870.820.860.740.74-0.3-0.07-0.530.850.210.660.520.180.580.250.650.12-0.77-0.730.870.930.760.10.81-0.130.790.07-0.86-0.72-0.57
-0.77-0.64-0.65-0.81-0.610.40.00.2-0.8-0.31-0.9-0.28-0.61-0.57-0.36-0.680.03-0.770.6-0.84-0.76-0.72-0.13-0.70.19-0.70.150.60.470.23
-0.51-0.44-0.4-0.67-0.220.27-0.020.24-0.540.32-0.6-0.280.23-0.67-0.25-0.350.0-0.730.6-0.56-0.89-0.42-0.54-0.640.45-0.90.230.620.930.36
0.820.750.720.890.7-0.46-0.09-0.440.830.340.630.320.440.540.370.7-0.130.87-0.84-0.560.80.770.010.750.070.640.31-0.71-0.53-0.41
0.690.670.630.740.48-0.450.0-0.530.7-0.10.670.320.00.640.160.47-0.020.93-0.76-0.890.80.580.350.76-0.340.83-0.13-0.85-0.86-0.6
0.960.890.880.70.90.02-0.11-0.210.960.690.520.760.510.490.580.960.240.76-0.72-0.420.770.58-0.340.570.360.690.34-0.37-0.41-0.12
-0.25-0.37-0.30.18-0.49-0.210.340.05-0.23-0.710.27-0.33-0.420.22-0.25-0.29-0.310.1-0.13-0.540.010.35-0.340.23-0.740.3-0.47-0.22-0.5-0.04
0.690.460.640.580.56-0.36-0.02-0.20.690.110.70.330.210.640.460.53-0.020.81-0.7-0.640.750.760.570.23-0.380.71-0.08-0.76-0.55-0.26
0.210.340.180.060.370.28-0.220.00.220.68-0.450.350.28-0.170.250.39-0.01-0.130.190.450.07-0.340.36-0.74-0.38-0.250.780.380.310.18
0.730.610.630.690.52-0.13-0.12-0.10.750.020.640.580.010.730.470.640.210.79-0.7-0.90.640.830.690.30.71-0.25-0.11-0.53-0.84-0.14
0.240.290.220.30.320.21-0.1-0.070.240.46-0.420.220.09-0.080.290.35-0.020.070.150.230.31-0.130.34-0.47-0.080.78-0.110.090.10.02
-0.58-0.55-0.62-0.54-0.460.430.030.55-0.550.1-0.58-0.11-0.03-0.460.0-0.240.05-0.860.60.62-0.71-0.85-0.37-0.22-0.760.38-0.530.090.590.74
-0.48-0.48-0.39-0.6-0.230.27-0.050.32-0.490.32-0.38-0.380.37-0.63-0.18-0.34-0.01-0.720.470.93-0.53-0.86-0.41-0.5-0.550.31-0.840.10.590.38
-0.26-0.48-0.36-0.28-0.210.360.020.9-0.210.21-0.190.090.17-0.10.360.080.03-0.570.230.36-0.41-0.6-0.12-0.04-0.260.18-0.140.020.740.38
Click cells to compare fundamentals
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Competition

Gilead Common Stock Shares Outstanding

Common Stock Shares Outstanding

1.47 Billion

At present, Gilead Sciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting.
According to the company disclosure, Gilead Sciences has an Earnings Per Share of 4.5 times. This is 46.24% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The earnings per share for all United States stocks is 44.23% lower than that of the firm.

Gilead Earnings Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gilead Sciences' direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Gilead Sciences could also be used in its relative valuation, which is a method of valuing Gilead Sciences by comparing valuation metrics of similar companies.
Gilead Sciences is currently under evaluation in earnings per share category among related companies.

Gilead Sciences ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Gilead Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Gilead Sciences' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Gilead Fundamentals

About Gilead Sciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Gilead Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gilead Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gilead Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company was incorporated in 1987 and is headquartered in Foster City, California. Gilead Sciences operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 14400 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:
Check out Gilead Sciences Piotroski F Score and Gilead Sciences Altman Z Score analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Gilead Stock analysis

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Transaction History
View history of all your transactions and understand their impact on performance
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.13)
Dividend Share
3
Earnings Share
4.5
Revenue Per Share
21.728
Quarterly Revenue Growth
(0.04)
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.